Monique Albersen1, Marjolein Bosma1, Jurjen J Luykx1, Judith J M Jans1, Steven C Bakker2, Eric Strengman1, Paul J Borgdorff1, Peter J M Keijzers2, Eric P A van Dongen1, Peter Bruins1, Monique G M de Sain-van der Velden1, Gepke Visser1, Nine V V A M Knoers1, Roel A Ophoff1, Nanda M Verhoeven-Duif1. 1. Department of Medical Genetics, University Medical Center Utrecht, Utrecht, Netherlands (MA, MB, JJMJ, ES, MGMdS-vdV, NVVAMK, and NMV-D); the Neurogenetics Unit (JJL) and the Department of Psychiatry (SCB and RAO), Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, Netherlands; the Department of Psychiatry, ZNA Hospitals, Antwerp, Belgium (JJL); the Department of Anesthesiology, Intensive Care and Pain Management, Diakonessenhuis Hospital, Utrecht, Netherlands (PJB); the Department of Anesthesiology, Central Military Hospital, Utrecht, Netherlands (PJMK); the Department of Anesthesiology, Intensive Care and Pain Management, St Antonius Hospital, Nieuwegein, Netherlands (EPAvD and PB); the Department of Pediatric Metabolic Diseases, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, Netherlands (GV); and the Center for Neurobehavioral Genetics, Semel Institute for Neuroscience and Human Behavior, University of California Los Angeles, Los Angeles, CA (RAO). 2. From the Department of Medical Genetics, University Medical Center Utrecht, Utrecht, Netherlands (MA, MB, JJMJ, ES, MGMdS-vdV, NVVAMK, and NMV-D); the Neurogenetics Unit (JJL) and the Department of Psychiatry (SCB and RAO), Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, Netherlands; the Department of Psychiatry, ZNA Hospitals, Antwerp, Belgium (JJL); the Department of Anesthesiology, Intensive Care and Pain Management, Diakonessenhuis Hospital, Utrecht, Netherlands (PJB); the Department of Anesthesiology, Central Military Hospital, Utrecht, Netherlands (PJMK); the Department of Anesthesiology, Intensive Care and Pain Management, St Antonius Hospital, Nieuwegein, Netherlands (EPAvD and PB); the Department of Pediatric Metabolic Diseases, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, Netherlands (GV); and the Center for Neurobehavioral Genetics, Semel Institute for Neuroscience and Human Behavior, University of California Los Angeles, Los Angeles, CA (RAO).
Abstract
BACKGROUND: Vitamin B-6 comprises a group of 6 interrelated vitamers and is essential for numerous physiologic processes, including brain functioning. Genetic disorders disrupting vitamin B-6 metabolism have severe clinical consequences. OBJECTIVE: To adequately diagnose known and novel disorders in vitamin B-6 metabolism, a reference set is required containing information on all vitamin B-6 vitamers in plasma and cerebrospinal fluid (CSF). DESIGN: Concentrations of vitamin B-6 vitamers in the plasma and CSF of 533 adult subjects were measured by ultra high-performance liquid chromatography-tandem mass spectrometry. RESULTS: The relative vitamin B-6 vitamer composition of plasma [pyridoxal phosphate (PLP) > pyridoxic acid (PA) > pyridoxal] differed from that of CSF (pyridoxal > PLP > PA > pyridoxamine). Sex influenced vitamin B-6 vitamer concentrations in plasma and CSF and should therefore be taken into account when interpreting vitamin B-6 vitamer concentrations. The strict ratios and strong correlations between vitamin B-6 vitamers point to a tight regulation of vitamin B-6 vitamer concentrations in blood and CSF. Given the unique design of this study, with simultaneously withdrawn blood and CSF from a large number of subjects, reliable CSF:plasma ratios and correlations of vitamin B-6 vitamers could be established. CONCLUSIONS: We provide an extensive reference set of vitamin B-6 vitamer concentrations in plasma and CSF. In addition to providing insight on the regulation of individual vitamers and their intercompartmental distribution, we anticipate that these data will prove to be a valuable reference set for the diagnosis and treatment of conditions associated with altered vitamin B-6 metabolism.
BACKGROUND:Vitamin B-6 comprises a group of 6 interrelated vitamers and is essential for numerous physiologic processes, including brain functioning. Genetic disorders disrupting vitamin B-6 metabolism have severe clinical consequences. OBJECTIVE: To adequately diagnose known and novel disorders in vitamin B-6 metabolism, a reference set is required containing information on all vitamin B-6 vitamers in plasma and cerebrospinal fluid (CSF). DESIGN: Concentrations of vitamin B-6 vitamers in the plasma and CSF of 533 adult subjects were measured by ultra high-performance liquid chromatography-tandem mass spectrometry. RESULTS: The relative vitamin B-6 vitamer composition of plasma [pyridoxal phosphate (PLP) > pyridoxic acid (PA) > pyridoxal] differed from that of CSF (pyridoxal > PLP > PA > pyridoxamine). Sex influenced vitamin B-6 vitamer concentrations in plasma and CSF and should therefore be taken into account when interpreting vitamin B-6 vitamer concentrations. The strict ratios and strong correlations between vitamin B-6 vitamers point to a tight regulation of vitamin B-6 vitamer concentrations in blood and CSF. Given the unique design of this study, with simultaneously withdrawn blood and CSF from a large number of subjects, reliable CSF:plasma ratios and correlations of vitamin B-6 vitamers could be established. CONCLUSIONS: We provide an extensive reference set of vitamin B-6 vitamer concentrations in plasma and CSF. In addition to providing insight on the regulation of individual vitamers and their intercompartmental distribution, we anticipate that these data will prove to be a valuable reference set for the diagnosis and treatment of conditions associated with altered vitamin B-6 metabolism.
Authors: Clio Rubinos; Maria Jose Bruzzone; Courtney Blodgett; Carolyn Tsai; Puja Patel; Rachel Hianik; Rakesh Jadav; Jordane Boudesseul; Chuning Liu; Hongtu Zhu; Susan E Wilson; Casey Olm-Shipman; Rick Meeker; Lawrence J Hirsch Journal: Neurocrit Care Date: 2022-09-07 Impact factor: 3.532
Authors: Nolan Kamitaki; Aswin Sekar; Robert E Handsaker; Heather de Rivera; Katherine Tooley; David L Morris; Kimberly E Taylor; Christopher W Whelan; Philip Tombleson; Loes M Olde Loohuis; Michael Boehnke; Robert P Kimberly; Kenneth M Kaufman; John B Harley; Carl D Langefeld; Christine E Seidman; Michele T Pato; Carlos N Pato; Roel A Ophoff; Robert R Graham; Lindsey A Criswell; Timothy J Vyse; Steven A McCarroll Journal: Nature Date: 2020-05-11 Impact factor: 49.962
Authors: Viorica Chelban; Matthew P Wilson; Jodi Warman Chardon; Jana Vandrovcova; M Natalia Zanetti; Eleni Zamba-Papanicolaou; Stephanie Efthymiou; Simon Pope; Maria R Conte; Giancarlo Abis; Yo-Tsen Liu; Eloise Tribollet; Nourelhoda A Haridy; Juan A Botía; Mina Ryten; Paschalis Nicolaou; Anna Minaidou; Kyproula Christodoulou; Kristin D Kernohan; Alison Eaton; Matthew Osmond; Yoko Ito; Pierre Bourque; James E C Jepson; Oscar Bello; Fion Bremner; Carla Cordivari; Mary M Reilly; Martha Foiani; Amanda Heslegrave; Henrik Zetterberg; Simon J R Heales; Nicholas W Wood; James E Rothman; Kym M Boycott; Philippa B Mills; Peter T Clayton; Henry Houlden Journal: Ann Neurol Date: 2019-07-01 Impact factor: 10.422
Authors: Monique Albersen; Marjolein Bosma; Judith J M Jans; Floris C Hofstede; Peter M van Hasselt; Monique G M de Sain-van der Velden; Gepke Visser; Nanda M Verhoeven-Duif Journal: PLoS One Date: 2015-03-11 Impact factor: 3.240